Article:
Blue Eyes Biotech Unveils World’s FirstTemperature-Stable Edelweiss Stem Cell Extract
In a landmark innovation, Blue Eyes BiotechCO., Ltd. debuts its patented Polar Edelweiss Stem Cell Extract, defyingindustry norms by maintaining 98% cellular viability at 25°C for 12 months—eliminatingcostly cold-chain logistics for global buyers.
This high-altitude alpine extract isclinically proven to:
- Boost fibroblast proliferation by 220%(vs. traditional refrigerated stem cells)
- Increase collagen synthesis by 35% in 3Dskin models
- Extend cellular longevity pathways(SIRT-1 activation +40%)
Why This Disrupts the Market:
✔No More Refrigeration: Proprietarylyophilization technology preserves membrane integrity without freezing.
✔Broader Formulation Applications: Stablein serums, capsules, injectables & functional beverages.
✔Supply Chain Freedom: Ships globallywithout temperature-controlled packaging.
Target Applications:
- Cosmetics: Bio-active anti-aging creams& regenerative toners
- Nutraceuticals: Oral longevitysupplements with 3x higher bioavailability
- Pharma: Wound-healing &tissue-regeneration matrices
For Ingredient Buyers & OEM Partners:
- Tech Dossier Available: Includescomparative Raman spectroscopy vs. cryopreserved stem cells
- Custom Potency Grades: 0.5%–5% activestem cell concentrations
- Ethical Sourcing: Wild-harvested under EUecological protocols
"This isn’t just stabilization—it’s atotal reinvention of plant stem cell economics," says Dr. Lena Müller, ourHead of Botanical R&D.
Get the Full Technical White Paper
Contact:[email protected] www.blueeyes-bio.com